Business OpportunityUpdated on 27 October 2025
Support on Advancing Sustainable and Innovative Healthcare Procurement Through Collaboration and Capacity Building
Health and Innovation Technician at Consorci de Salut i Social de Catalunya
Barcelona, Spain
About
CSC has extensive experience in European initiatives, particularly in healthcare procurement, innovation, and sustainability. It has participated in ProCure (EU4H) on procurement practices after COVID-19, RaDAR (EISMEA) on antimicrobial resistance detection through cross-border procurement, and Procure4Health (HORIZON-CSA) on innovation ecosystems in health and social care. CSC is also involved in the European Commission Big Buyers communities of practice on healthcare sustainability and efficiency, and is a member of the Global Green and Healthy Hospitals (GGHH) network, promoting sustainable healthcare worldwide.
CSC can contribute by combining its multi-actor network (municipalities, health agencies, hospitals, social care entities) with its practical expertise in procurement, sustainability, solution validation and innovation. CSC can host and coordinate workshops, training schools, and short-term scientific missions, fostering inclusive cooperation and capacity building. Furthermore, CSC is well positioned to ensure effective dissemination, stakeholder engagement, and policy impact at local, national, and European levels, strengthening the societal relevance of the Action.
Stage
- TRL 6
- TRL 7
- TRL 8
Topic
- Cardiovascular
- Diseases of the blood and immune disorders
- Diseases of the eye
- Endocrine/nutritional/metabolic diseases
- Physiology
- Genomics
- Infectious and parasitic diseases
- Mental and behavioural disorders / psychiatry /psychology
- Neoplasms/cancer/oncology
- Diseases of the nervous system / neurology
- Pregnancy, childbirth and the puerperium
- Respiratory
- Other
- Pediatrics
- Rare diseases
Sector
- Health data
- ATMPs
- AI
- Diagnostics
- Oncology
- Rare diseases
- Other
Type
- Research collaboration
- Co-development
- Clinical validation
- Regulatory expert
- Consortium partners
Organisation
Similar opportunities
Business Opportunity
- TRL 6
- TRL 7
- TRL 8
- Health data
- Rare diseases
- Research collaboration
- Congenital or chromosomal abnormalities
- Diseases of the blood and immune disorders
Jacques Riviere
Pediatric immunologist, researcher at Vall d'Hebron Research Institute (VHIR)
Barcelona, Spain
Business Opportunity
vitalera: Making Hospital-at-Home a Reality with AI
- AI
- TRL 8
- Oncology
- Physiology
- Pediatrics
- Licensing
- Respiratory
- Health data
- Rare diseases
- Rare diseases
- Bioinformatics
- Cardiovascular
- Co-development
- Digestive system
- Consortium partners
- Regenerative medicine
- Research collaboration
- External causes of morbidity, mortality
- Injury, poisoning, other external causes
- Pregnancy, childbirth and the puerperium
- Musculoskeletal system, connective tissue
- Other symptoms, deviant clinical findings
- Diseases of the blood and immune disorders
- Diseases of the nervous system / neurology
- Mental and behavioural disorders / psychiatry /psychology
Nuria Pastor
General Manager at vitalera
Barcelona, Spain
Business Opportunity
- TRL 6
- TRL 7
- TRL 8
- ATMPs
- Rare diseases
- Cardiovascular
- Co-development
- Digestive system
- Diseases of the ear
- Diseases of the eye
- Consortium partners
- Genitourinary system
- Research collaboration
- Skin and subcutaneous tissue
- Musculoskeletal system, connective tissue
- Diseases of the blood and immune disorders
- Diseases of the nervous system / neurology
Friederike Eilts
Team lead process technologies at Fraunhofer IGB